Cardiovascular Metrics

ViiV gains US approval for newborn HIV treatment

Newborn HIV treatment gets US FDA approval as ViiV's Tivicay PD becomes the first second‑gen INSTI cleared for infants 2 kg or heavier, widening options.

By Ava Brown · Aug 29, 2026
Cardiovascular Metrics

Isomab Shows Safe Blood Vessel Growth in CAD

Pro angiogenic therapy shows safe blood vessel growth in coronary artery disease, with a systematic review of 11 studies finding no new risks for patients.

By Maya Puspitasari · Aug 29, 2026